tyrosyl-alanyl-glycyl-N(alpha)-methylphenylalanine chloromethyl ketone: mu specific affinity label for opioid receptor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 5487344 |
| MeSH ID | M0150016 |
| Synonym |
|---|
| tyr-ala-gly-n(alpha)-mephe-chloromethyl ketone |
| damck |
| damk |
| tyr-ala-gly-mephe chloromethyl ketone |
| 109377-04-0 |
| tyr-ala-gly-mephe-cmk |
| glycinamide, l-tyrosyl-d-alanyl-n-(3-chloro-2-oxo-1-(phenylmethyl)propyl)-n-methyl-, (s)- |
| tyrosyl-alanyl-glycyl-methylphenylalanyl chloromethyl ketone |
| tyrosyl-alanyl-glycyl-n(alpha)-methylphenylalanine chloromethyl ketone |
| (2s)-2-amino-n-[(2r)-1-[[2-[[(2s)-4-chloro-3-oxo-1-phenylbutan-2-yl]-methylamino]acetyl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide |
| DTXSID60911148 |
| 2-amino-n-[1-({2-[(4-chloro-3-oxo-1-phenylbutan-2-yl)(methyl)amino]-1-hydroxyethylidene}amino)-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanimidic acid |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.84) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||